FUJI PHARMA
FUJI PHARMA, a prominent player in the pharmaceutical industry, is headquartered in Thailand (TH) and operates extensively across Southeast Asia. Founded in 1985, the company has established itself as a leader in the development and distribution of high-quality generic and branded medications, focusing on therapeutic areas such as cardiology, oncology, and infectious diseases. With a commitment to innovation, FUJI PHARMA offers a diverse portfolio of products that stand out for their efficacy and safety. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market presence. Recognised for its dedication to quality and patient care, FUJI PHARMA continues to strengthen its position in the competitive pharmaceutical landscape, making strides towards improving health outcomes across the region.
DitchCarbon Score
How does FUJI PHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
FUJI PHARMA's score of 3 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
FUJI PHARMA's reported carbon emissions
FUJI PHARMA, headquartered in Thailand, currently does not provide specific carbon emissions data or reduction targets. As of now, there are no reported figures regarding their Scope 1, 2, or 3 emissions, nor any documented climate commitments or initiatives aimed at reducing their carbon footprint. This absence of data highlights a potential area for improvement in transparency and accountability regarding their environmental impact. In the pharmaceutical industry, companies are increasingly expected to set ambitious climate targets and report on their emissions to align with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
FUJI PHARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
